Pharmas' reputations matter, especially when it comes to writing prescriptions, new survey finds
What’s in a pharma’s corporate reputation? Healthcare providers’ willingness to write a prescription, according to a new study from WE Communications.
Two-thirds of healthcare providers said they are reluctant to prescribe a drug from a pharma that does not have a good reputation, according to the study report. The survey queried more than 1,000 healthcare providers in six countries — Australia, China, Germany, India, UK and US — about biotech and pharma corporate brands and the connection to products they would recommend or prescribe.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.